vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and NPK International Inc. (NPKI). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $75.2M, roughly 1.6× NPK International Inc.). On growth, NPK International Inc. posted the faster year-over-year revenue change (30.7% vs 4.7%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $5.8M). Over the past eight quarters, NPK International Inc.'s revenue compounded faster (23.9% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
NATR vs NPKI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $75.2M |
| Net Profit | $4.1M | — |
| Gross Margin | 72.5% | 37.7% |
| Operating Margin | 4.3% | 16.7% |
| Net Margin | 3.3% | — |
| Revenue YoY | 4.7% | 30.7% |
| Net Profit YoY | 1379.4% | — |
| EPS (diluted) | $0.23 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $75.2M | ||
| Q3 25 | $128.3M | $68.8M | ||
| Q2 25 | $114.8M | $68.2M | ||
| Q1 25 | $113.2M | $64.8M | ||
| Q4 24 | $118.2M | $57.5M | ||
| Q3 24 | $114.6M | $44.2M | ||
| Q2 24 | $110.6M | $66.8M | ||
| Q1 24 | $111.0M | $49.0M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $5.3M | $5.7M | ||
| Q2 25 | $5.3M | $8.7M | ||
| Q1 25 | $4.7M | $10.0M | ||
| Q4 24 | $-321.0K | — | ||
| Q3 24 | $4.3M | $-174.3M | ||
| Q2 24 | $1.3M | $8.0M | ||
| Q1 24 | $2.3M | $7.3M |
| Q4 25 | 72.5% | 37.7% | ||
| Q3 25 | 73.3% | 31.9% | ||
| Q2 25 | 71.7% | 36.9% | ||
| Q1 25 | 72.1% | 39.0% | ||
| Q4 24 | 72.0% | 39.2% | ||
| Q3 24 | 71.3% | 27.5% | ||
| Q2 24 | 71.4% | 37.2% | ||
| Q1 24 | 71.2% | 36.0% |
| Q4 25 | 4.3% | 16.7% | ||
| Q3 25 | 7.0% | 13.2% | ||
| Q2 25 | 3.7% | 17.0% | ||
| Q1 25 | 5.4% | 20.9% | ||
| Q4 24 | 3.8% | 20.2% | ||
| Q3 24 | 4.6% | 2.8% | ||
| Q2 24 | 5.1% | 18.7% | ||
| Q1 24 | 4.2% | 14.2% |
| Q4 25 | 3.3% | — | ||
| Q3 25 | 4.2% | 8.2% | ||
| Q2 25 | 4.6% | 12.7% | ||
| Q1 25 | 4.2% | 15.4% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 3.8% | -394.3% | ||
| Q2 24 | 1.2% | 12.0% | ||
| Q1 24 | 2.1% | 14.9% |
| Q4 25 | $0.23 | $0.17 | ||
| Q3 25 | $0.30 | $0.07 | ||
| Q2 25 | $0.28 | $0.10 | ||
| Q1 25 | $0.25 | $0.11 | ||
| Q4 24 | $-0.02 | $0.10 | ||
| Q3 24 | $0.23 | $-1.99 | ||
| Q2 24 | $0.07 | $0.09 | ||
| Q1 24 | $0.12 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $5.1M |
| Total DebtLower is stronger | — | $16.9M |
| Stockholders' EquityBook value | $161.6M | $351.2M |
| Total Assets | $261.1M | $441.8M |
| Debt / EquityLower = less leverage | — | 0.05× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $5.1M | ||
| Q3 25 | $95.6M | $35.6M | ||
| Q2 25 | $81.3M | $26.0M | ||
| Q1 25 | $86.5M | $20.8M | ||
| Q4 24 | $84.7M | $17.8M | ||
| Q3 24 | $78.7M | $42.9M | ||
| Q2 24 | $68.7M | $35.1M | ||
| Q1 24 | $77.8M | $37.7M |
| Q4 25 | — | $16.9M | ||
| Q3 25 | — | $9.5M | ||
| Q2 25 | — | $9.3M | ||
| Q1 25 | — | $8.1M | ||
| Q4 24 | — | $7.7M | ||
| Q3 24 | — | $14.0M | ||
| Q2 24 | — | $58.0M | ||
| Q1 24 | $2.1M | $77.4M |
| Q4 25 | $161.6M | $351.2M | ||
| Q3 25 | $166.7M | $333.9M | ||
| Q2 25 | $163.7M | $328.8M | ||
| Q1 25 | $167.1M | $326.9M | ||
| Q4 24 | $161.0M | $326.5M | ||
| Q3 24 | $162.6M | $316.5M | ||
| Q2 24 | $156.4M | $426.6M | ||
| Q1 24 | $159.7M | $421.6M |
| Q4 25 | $261.1M | $441.8M | ||
| Q3 25 | $264.8M | $404.5M | ||
| Q2 25 | $254.9M | $393.7M | ||
| Q1 25 | $252.7M | $390.0M | ||
| Q4 24 | $240.9M | $393.7M | ||
| Q3 24 | $245.3M | $389.6M | ||
| Q2 24 | $235.8M | $624.8M | ||
| Q1 24 | $247.3M | $640.8M |
| Q4 25 | — | 0.05× | ||
| Q3 25 | — | 0.03× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | 0.01× | 0.18× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $18.0M |
| Free Cash FlowOCF − Capex | $7.6M | $5.8M |
| FCF MarginFCF / Revenue | 6.1% | 7.6% |
| Capex IntensityCapex / Revenue | 1.9% | 16.3% |
| Cash ConversionOCF / Net Profit | 2.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $26.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $18.0M | ||
| Q3 25 | $18.5M | $24.7M | ||
| Q2 25 | $4.3M | $21.4M | ||
| Q1 25 | $2.6M | $8.8M | ||
| Q4 24 | $12.2M | $-4.1M | ||
| Q3 24 | $9.6M | $2.8M | ||
| Q2 24 | $1.3M | $27.6M | ||
| Q1 24 | $2.2M | $11.9M |
| Q4 25 | $7.6M | $5.8M | ||
| Q3 25 | $16.8M | $12.0M | ||
| Q2 25 | $3.0M | $9.7M | ||
| Q1 25 | $1.5M | $-1.2M | ||
| Q4 24 | $10.0M | $-17.7M | ||
| Q3 24 | $7.9M | $-6.7M | ||
| Q2 24 | $-2.0M | $21.0M | ||
| Q1 24 | $-1.5M | $-1.9M |
| Q4 25 | 6.1% | 7.6% | ||
| Q3 25 | 13.1% | 17.4% | ||
| Q2 25 | 2.6% | 14.3% | ||
| Q1 25 | 1.3% | -1.8% | ||
| Q4 24 | 8.5% | -30.8% | ||
| Q3 24 | 6.9% | -15.2% | ||
| Q2 24 | -1.9% | 31.4% | ||
| Q1 24 | -1.4% | -3.9% |
| Q4 25 | 1.9% | 16.3% | ||
| Q3 25 | 1.3% | 18.5% | ||
| Q2 25 | 1.2% | 17.1% | ||
| Q1 25 | 1.0% | 15.5% | ||
| Q4 24 | 1.9% | 23.6% | ||
| Q3 24 | 1.5% | 21.4% | ||
| Q2 24 | 3.0% | 9.9% | ||
| Q1 24 | 3.3% | 28.3% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | 4.37× | ||
| Q2 25 | 0.81× | 2.47× | ||
| Q1 25 | 0.55× | 0.88× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | 3.43× | ||
| Q1 24 | 0.94× | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
NPKI
| Rental Revenue | $34.8M | 46% |
| Products | $25.5M | 34% |
| Services | $14.9M | 20% |
